Final Program

32 SUNDAY • MAY 15
Target Audience
Clinicians, researchers and educators with an interest in lung cancer and in
global lung health.
Objectives
At the conclusion of this session, the participant will be able to:
• learn new findings about best practices for early detection of lung cancer;
• apply recent guidelines and policy statements to be able to better diagnose
and stage lung cancer;
• integrate new treatment and prevention options in discussing lung cancer
with patients.
Lung cancer is the leading cause of cancer death in the world. The challenge to
decrease lung cancer mortality through prevention, early detection, rapid
diagnosis, staging, and precision therapy is global; yet approaches to these
efforts vary. Speakers for this session are drawn from the International
Relations Working Group of the ATS Thoracic Oncology Assembly with leaders
from ATS, JRS, ERS, the Chinese Respiratory Association, and the Latin
American Thoracic Association. Topics will include prevention, lung cancer
screening, precision therapy, updates in lung cancer classification and staging,
and quality benchmarks for diagnosis and treatment.
Chairing: C.A. Powell, MD, New York, NY
M. Gaga, MD, PhD, Athens, Greece
S. Quadrelli, MD, PhD, Buenos Aires, Argentina
C. Bai, MD, PhD, Shanghai, China
9:00 The Role of Smoking Cessation in the Prevention of Lung
Cancer
J.M. Samet, MD, MS, Los Angeles, CA
9:20 WHO-IARC, IASLC-ATS Updates of Lung Cancer Classification,
C.A. Powell, MD, New York, NY
9:40 Integration of Imaging and Molecular Biomarkers for Lung
Cancer Detection
C. Bai, MD, PhD, Shanghai, China
10:00 Screening for Lung Cancer: Maximizing Benefits and
Minimizing Harms
M.K. Gould, MD, MS, Pasadena, CA
10:20 Precision Therapy of Lung Cancer: Targets, Resistance, and
Opportunities
K. Kiura, MD, PhD, Okayama, Japan
10:40 European Initiative for Quality Management in Lung Cancer
Care
M. Gaga, MD, PhD, Athens, Greece
This session and the International Conference are supported by an educational grant from
AstraZeneca LP.
All CME sessions have been planned and implemented in accordance with the Essential
Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME)
and are free of the control of commercial interests
A12
BASIC • CLINICAL • TRANSLATIONAL
SCIENTIFIC SYMPOSIUM
CME Credits Available: 2.0
ENTREPRENEURSHIP: EMBRACING THE
INNOVATIVE ENVIRONMENT - FROM BENCH TO
BOARDROOM TO BEDSIDE
Drug and Device Discovery Development Committee
9:00 a.m. - 11:00 a.m. MOSCONE CENTER
Room 3010/3012 (West Building, Level 3)
Target Audience
Basic,translational and clinical investigators and those responsible for
translating knowledge into innovations in academia, government, nonprofits
and industry.
Objectives
At the conclusion of this session, the participant will be able to:
• understand how to turn discoveries into innovations;
• find funding sources for innovations;
• grow one’s career.
The symposium will show the importance of entrepreneurship in creating an
innovative environment. The session will focus on successful examples of
entrepreneurship and innovation in big pharma, academia, biotech and
government. Speakers will discuss different entrepreneurial mechanisms
currently used to identify and fund innovation, including venture capital,
philanthropy, patient support organizations and government (e.g., NIH, NSF)
Small Business Innovation Research/Small Business Technology Transfer
(SBIR/STTR), and their applicability to a diverse ATS membership. Regulatory
insights will be provided into alternative pathways to develop and secure
approval for innovative drugs and devices.
Chairing: T.F. Reiss, MD, New Hope, PA
J. Moss, MD, PhD, Bethesda, MD
9:00 The Innovative Mindset
M. Turner, PhD, Westfield, NJ
9:24 Entrepreneurship: Academic Insights into Technology
Transfer
C. Wyskiel, MBA, Baltimore, MD
9:48 Early Lessons in Entrepreneurship: A Venture Capital
Perspective
C. Berkland, PhD, Lawrence, KS
10:12 SBIR/STTR Grants: Funding the Path from Academia to
Industry
C.G. Irvin, PhD, Burlington, VT
10:36 The Cystic Fibrosis Foundation: A Profitable Non-Profit’s
Guide to Therapeutic Success
R.J. Beall, PhD, Bethesda, MD
ATS 2016 • San Francisco